Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jan 2008

Chetrit Angela, Hirsh-Yechezkel Galit, Ben-David Yehuda, Lubin Flora, Friedman Eitan, Sadetzki Siegal

Abstract excerpt

PURPOSE: To evaluate the long-term survival of ovarian cancer (OvC) patients in total and by BRCA1/2 mutation status. PATIENTS AND METHODS: In a nationwide case-control study on OvC conducted in Israel between 1994 and 1999, 779 Jewish women with epithelial invasive OvC were tested for the three Ashkenazi Jewish founder mutations in BRCA1 (185delAG; 5382insC) and BRCA2 (6174delT) genes and followed for survival...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystadenocarcinoma, Serous
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Israel

Share to Neoplasm Invasiveness

Share to Survival Rate

Source

Identifiers

PMID: 18165636
DOI: 10.1200/JCO.2007.11.6905

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.PMID 18165636Read ↗

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.Semantic proximity Read ↗

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.Semantic proximity Read ↗

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian TumorsSemantic proximity Read ↗

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.Semantic proximity Read ↗

Effect of <i>BRCA</i> Mutations on the Length of Survival in Epithelial Ovarian TumorsSemantic proximity Read ↗

Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian CancerSemantic proximity Read ↗

Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.Semantic proximity Read ↗

Improved survival in BRCA2 carriers with ovarian cancer.Semantic proximity Read ↗

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.